Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Pancreatic Neoplasms 8Rectal Neoplasms 4Anus Neoplasms 4Urinary Bladder Neoplasms 3Pancreatic Adenocarcinoma 3Ovarian Neoplasms 2Klatskin Tumor 2Gallbladder Neoplasms 2Esophageal Neoplasms 2Colorectal Neoplasms 2Cholangiocarcinoma 2Anal Canal Carcinoma 2Adenocarcinoma Of Esophagus 2Urethral Neoplasms 1Ureteral Neoplasms 1Testicular Neoplasms 1Stomach Neoplasms 1Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1Somatostatinoma 1Sinonasal undifferentiated carcinoma 1Paranasal Sinus Neoplasms 1Neoplasm Metastasis 1Metastatic Small Intestinal Adenocarcinoma 1Lung Neoplasms 1Keratosis, Actinic 1HIV Infections 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Clinical Stage I Gastric Cancer AJCC v8 1Clinical Stage 0 Gastric Cancer AJCC v8 1

Interventions

Carboplatin 15Etoposide 14Ifosfamide 11Paclitaxel 10Filgrastim 10Cisplatin 10Thiotepa 5Peripheral Blood Stem Cell Transplantation 5Gemcitabine 5pegfilgrastim 4Cyclophosphamide 4Bleomycin 4etoposide phosphate 3Oxaliplatin 3Methylprednisolone 3Epirubicin 3sargramostim 2aldesleukin 2Stem Cell Transplantation 2Prednisone 2Methotrexate 2Mesna 2Melphalan 2Granulocyte Colony-Stimulating Factor 2Docetaxel 2Dexamethasone 2Brentuximab Vedotin 2Arsenic Trioxide 2Amifostine 2Alemtuzumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Testicular Neoplasms × dehydroftorafur × Clear all
NCT00957905 2017-03-10

Alvocidib and Oxaliplatin With or Without Fluorouracil and Leucovorin Calcium in Treating Patients With Relapsed or Refractory Germ Cell Tumors

National Cancer Institute (NCI)

Phase 2 Completed
36 enrolled 7 charts
Genitourinary

Testicular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡